Skip to main content
Video-Teleconferencing in Pediatric Neuro-Oncology: Ten Years of Experience.
- Author(s): Amayiri, Nisreen;
- Swaidan, Maisa;
- Abuirmeileh, Najiyah;
- Al-Hussaini, Maysa;
- Tihan, Tarik;
- Drake, James;
- Musharbash, Awni;
- Qaddoumi, Ibrahim;
- Tabori, Uri;
- Halalsheh, Hadeel;
- Bartels, Ute;
- Bouffet, Eric
- et al.
Published Web Locationhttps://doi.org/10.1200/jgo.2016.008276
PurposeThe management of central nervous system tumors is challenging in low- and middle-income countries. Little is known about applicability of twinning initiatives with high-income countries in neuro-oncology. In 2004, a monthly neuro-oncology video-teleconference program was started between King Hussein Cancer Center (Amman, Jordan) and the Hospital for Sick Children (Toronto, Ontario, Canada). More than 100 conferences were held and > 400 cases were discussed. The aim of this work was to assess the sustainability of such an initiative and the evolution of the impact over time.
MethodsWe divided the duration in to three eras according to the initial 2 to 3 years of work of three consecutive oncologists in charge of the neuro-oncology program at King Hussein Cancer Center. We retrospectively reviewed the written minutes and compared the preconference suggested plans with the postconference recommendations. Impact of changes on the patient care was recorded.
ResultsThirty-three sets of written minutes (covering 161 cases) in the middle era and 32 sets of written minutes (covering 122 cases) in the last era were compared with the initial experience (20 meetings, 72 cases). Running costs of these conferences has dropped from $360/h to < $40/h. Important concepts were introduced, such as multidisciplinary teamwork, second-look surgery, and early referral. Suggestions for plan changes have decreased from 44% to 30% and 24% in the respective consecutive eras. Most recommendations involved alternative intervention modalities or pathology review. Most of these recommendations were followed.
ConclusionVideo-teleconferencing in neuro-oncology is feasible and sustainable. With time, team experience is built while the percentage and the type of treatment modifications change. Commitment and motivation helped maintain this initiative rather than availability of financial resources. Improvement in patients' care was achieved, in particular, with the implementation of a multidisciplinary team and the continuous effort to implement recommendations.
For improved accessibility of PDF content, download the file to your device.